Our previous study shows that IL-33 is released from oligodendrocytes and astrocytes early after stroke, and the activation of IL-33 receptor, ST2, protects against acute ischemic neuronal and oligodendrocyte loss (6, 7). Here, IL33 is linked to stroke disorder.